IMP stock transactions in November 2012
Liquidity dropped to its lowest level in over a year. Investors remained cautious due to market instability and the weak business performance of many companies.
The total trading volume of IMP shares in November was 11,390 shares, reflecting an improvement in liquidity compared to October but still at a low level.
Imexpharm's finacial performance (VND billion)
| Indicator |
November 2012 |
Cumulative 11 months |
% of 2012 Plan |
| Total Revenue and Income |
80.5 |
718.7 |
80.8% |
| Net Revenue |
79.7 |
709.0 |
|
| Pre-Tax Profit |
10.3 |
107.7 |
97.9% |
Board resolution on listing additional bonus shares
On November 1, 2012, the Board of Directors issued Resolution No. 65/NQ-HĐQT regarding the listing and depository of all additional bonus shares issued to existing shareholders (1,491,310 shares), increasing the total registered listed shares to 16,705,810.
On November 19, 2012, the Ho Chi Minh City Stock Exchange issued Notice No. 919/2012/TB-SGDHCM, stating the effective listing date as November 14, 2012, with official trading commencing on November 26, 2012.
Ongoing projects
Binh Duong Penicillin Plant Project: The equipment validation and mock production have been completed. Awaiting GMP-WHO approval from the Drug Administration of Vietnam.
ERP Project: By the end of November 2012, the project completed the trial phase of cross-functional process testing using Imexpharm’s real data. Preparations are underway to develop training materials for end-user training in December 2012.
Download: 2013/11/14/ban_tin_thang_112012.pdf